Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

BACKGROUND: We aimed to examine the safety and efficacy of bevacizumab and carboplatin in patients with breast cancer brain metastases. METHODS: We enrolled patients with breast cancer and > 1 measurable new or progressive brain metastasis. Patients received bevacizumab 15 mg/kg intravenously (IV...

詳細記述

保存先:
書誌詳細
出版年:Breast Cancer Res
主要な著者: Leone, Jose Pablo, Emblem, Kyrre E., Weitz, Michelle, Gelman, Rebecca S., Schneider, Bryan P., Freedman, Rachel A., Younger, Jerry, Pinho, Marco C., Sorensen, A. Gregory, Gerstner, Elizabeth R., Harris, Gordon, Krop, Ian E., Morganstern, Daniel, Sohl, Jessica, Hu, Jiani, Kasparian, Elizabeth, Winer, Eric P., Lin, Nancy U.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7706261/
https://ncbi.nlm.nih.gov/pubmed/33256829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-01372-w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料